{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:17:18Z","timestamp":1790713038826,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Thoracic aortic dissection (TAD) is a life-threatening disease with no effective drug therapy thus far. New therapeutic targets and indications for timely surgical intervention are urgently needed. Our aim is to investigate new pathological mechanisms and potential biomarkers of TAD through global metabolomic profiling of aortic aneurysm and dissection patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>\n                      We performed untargeted metabolomics to determine plasma metabolite concentrations in an aortic disease cohort, including 70 thoracic aortic aneurysm (TAA) and 70 TAD patients, as well as 70 healthy controls. Comparative analysis revealed that sphingolipid, especially its core metabolite C18-ceramide, was significantly distinguished in TAD patients but not in TAA patients, which was confirmed by subsequent quantitative analysis of C18-ceramide in a validation cohort. By analyzing our existing multiomics data in aortic tissue in a murine TAD model and TAD patients, we found that an enhanced ceramide\n                      <jats:italic>de novo<\/jats:italic>\n                      synthesis pathway in macrophages might contribute to the elevated ceramide. Inhibition of the ceramide\n                      <jats:italic>de novo<\/jats:italic>\n                      synthesis pathway by myriocin markedly alleviated BAPN-induced aortic inflammation and dissection in mice.\n                      <jats:italic>In vitro<\/jats:italic>\n                      studies demonstrated that exogenous C18-ceramide promoted macrophage inflammation and matrix metalloprotein (MMP) expression through the NLRP3-caspase 1 pathway. In contrast, inhibition of endogenous ceramide synthesis by myriocin attenuated lipopolysaccharide (LPS)-induced macrophage inflammation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrated that ceramide metabolism disturbance might play a vital role in TAD development by aggravating aortic inflammation through the NLRP3 pathway, possibly providing a new target for pharmacological therapy and a potential biomarker of TAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2022.826861","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T01:29:59Z","timestamp":1644283799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Metabolomic Profile Reveals That Ceramide Metabolic Disturbance Plays an Important Role in Thoracic Aortic Dissection"],"prefix":"10.3389","volume":"9","author":[{"given":"Hang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.lanwpc.2021.100280","article-title":"Incidence and survival of aortic dissection in Urban China: results from the National Insurance Claims for Epidemiological Research (NICER) study","volume":"17","author":"Tang","year":"2021","journal-title":"Lancet Regional Health Western Pacific."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/CIRCULATIONAHA.107.702720","article-title":"Aortic diameter >or = 55 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD)","volume":"116","author":"Pape","year":"2007","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0176727","DOI":"10.1371\/journal.pone.0176727","article-title":"Metabolomic profiling of ascending thoracic aortic aneurysms and dissections - implications for pathophysiology and biomarker discovery","volume":"12","author":"Doppler","year":"2017","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejvs.2018.07.004","article-title":"Identification of lysophosphatidylcholines and sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics","volume":"57","author":"Zhou","year":"2019","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.avsg.2020.06.026","article-title":"Identification of serum biomarker in acute aortic dissection by global and targeted metabolomics","volume":"68","author":"Zeng","year":"2020","journal-title":"Ann Vasc Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"757022","DOI":"10.3389\/fcvm.2021.757022","article-title":"Plasma lipidomics identifies unique lipid signatures and potential biomarkers for patients with aortic dissection","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ebiom.2019.09.041","article-title":"Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1alpha-ADAM17 pathway","volume":"49","author":"Lian","year":"2019","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/eurheartj\/ehab605","article-title":"Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection","volume":"42","author":"Cui","year":"2021","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jacbts.2017.12.005","article-title":"Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction","volume":"3","author":"de Carvalho","year":"2018","journal-title":"JACC Basic Transl Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide remodeling and risk of cardiovascular events and mortality","volume":"7","author":"Peterson","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e012853","DOI":"10.1161\/JAHA.119.012853","article-title":"Plasma ceramides and sphingomyelins in relation to atrial fibrillation risk: the cardiovascular health study","volume":"9","author":"Jensen","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J Clin Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00395-016-0533-x","article-title":"Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury","volume":"111","author":"Reforgiato","year":"2016","journal-title":"Basic Res Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","article-title":"nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe(-\/-) mice","volume":"38","author":"Lallemand","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-021-00362-2","article-title":"Single-cell RNA-seq identifies a Il1rn+\/Trem1+ macrophage subpopulation as a cellular target for mitigating the progression of thoracic aortic aneurysm and dissection","author":"Liu","year":"","journal-title":"Cell Discov"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.23736\/S0392-9590.16.03618-X","article-title":"Vitamins and abdominal aortic aneurysm","volume":"123","author":"Takagi","year":"2013","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.3390\/ijms222111737","article-title":"Vitamin B mitigates thoracic aortic dilation in marfan syndrome mice by restoring the canonical TGF-\u03b2 pathway","volume":"22","author":"Huang","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-015-0053-y","article-title":"Sphingolipids in cardiovascular diseases and metabolic disorders","volume":"14","author":"Borodzicz","year":"2015","journal-title":"Lipid Health Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fphys.2020.00054","article-title":"The role of macrophages in aortic dissection","volume":"11","author":"Wang","year":"2020","journal-title":"Front Physiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI60415","article-title":"Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis","volume":"123","author":"Chakraborty","year":"2013","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab."},{"key":"B27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.celrep.2011.11.005","article-title":"The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence","volume":"1","author":"Youm","year":"2012","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/jnc.14225","article-title":"Activation of the NLRP3 inflammasome in microglia: the role of ceramide","volume":"143","author":"Scheiblich","year":"2017","journal-title":"J Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/ATVBAHA.116.307648","article-title":"NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: implications for aortic biomechanical dysfunction and aneurysm and dissection formation","volume":"37","author":"Wu","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e014044","DOI":"10.1161\/JAHA.119.014044","article-title":"Targeting the NLRP3 inflammasome with inhibitor MCC950 prevents aortic aneurysms and dissections in mice","volume":"9","author":"Ren","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/1074248420919966","article-title":"PKM2 activator TEPP-46 attenuates thoracic aortic aneurysm and dissection by inhibiting NLRP3 inflammasome-mediated IL-1beta secretion","volume":"25","author":"Le","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.826861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T01:30:01Z","timestamp":1644283801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.826861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":31,"alternative-id":["10.3389\/fcvm.2022.826861"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.826861","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"article-number":"826861"}}